Literature DB >> 25162885

Updating cost-effectiveness--the curious resilience of the $50,000-per-QALY threshold.

Peter J Neumann1, Joshua T Cohen, Milton C Weinstein.   

Abstract

Mesh:

Year:  2014        PMID: 25162885     DOI: 10.1056/NEJMp1405158

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  590 in total

1.  Economic Analysis of a Three-Arm RCT Exploring the Delivery of Intensive, Prophylactic Swallowing Therapy to Patients with Head and Neck Cancer During (Chemo)Radiotherapy.

Authors:  Laurelie R Wall; Sanjeewa Kularatna; Elizabeth C Ward; Bena Cartmill; Anne J Hill; Elizabeth Isenring; Joshua Byrnes; Sandro V Porceddu
Journal:  Dysphagia       Date:  2018-12-04       Impact factor: 3.438

2.  Prophylactic Fixation Can Be Cost-effective in Preventing a Contralateral Bisphosphonate-associated Femur Fracture.

Authors:  Sam Y Jiang; David J Kaufman; Bonnie Y Chien; Michael Longoria; Ross Shachter; Julius A Bishop
Journal:  Clin Orthop Relat Res       Date:  2019-03       Impact factor: 4.176

3.  Cost-Effectiveness of Transjugular Intrahepatic Portosystemic Shunt versus Large-Volume Paracentesis in Refractory Ascites: Results of a Markov Model Incorporating Individual Patient-Level Meta-Analysis and Nationally Representative Cost Data.

Authors:  Sharon W Kwan; Stephen K Allison; Laura S Gold; David S Shin
Journal:  J Vasc Interv Radiol       Date:  2018-11-02       Impact factor: 3.464

Review 4.  Cost-effectiveness of New Targeted Agents in the Treatment of Chronic Lymphocytic Leukemia.

Authors:  R Andrew Harkins; Sharvil P Patel; Christopher R Flowers
Journal:  Cancer J       Date:  2019 Nov/Dec       Impact factor: 3.360

5.  Clinical Impact and Cost-effectiveness of Genotype Testing at Human Immunodeficiency Virus Diagnosis in the United States.

Authors:  Emily P Hyle; Justine A Scott; Paul E Sax; Lucia R I Millham; Caitlin M Dugdale; Milton C Weinstein; Kenneth A Freedberg; Rochelle P Walensky
Journal:  Clin Infect Dis       Date:  2020-03-17       Impact factor: 9.079

6.  Cost-Effectiveness of Patent Foramen Ovale Closure Versus Medical Therapy for Secondary Stroke Prevention.

Authors:  Michelle H Leppert; Sharon N Poisson; John D Carroll; David E Thaler; Chong H Kim; Karen D Orjuela; P Michael Ho; James F Burke; Jonathan D Campbell
Journal:  Stroke       Date:  2018-05-02       Impact factor: 7.914

7.  Cost-Effectiveness of a Technology-Facilitated Depression Care Management Adoption Model in Safety-Net Primary Care Patients with Type 2 Diabetes.

Authors:  Joel W Hay; Pey-Jiuan Lee; Haomiao Jin; Jeffrey J Guterman; Sandra Gross-Schulman; Kathleen Ell; Shinyi Wu
Journal:  Value Health       Date:  2017-12-06       Impact factor: 5.725

8.  Clinical and Economic Evaluation of Treatment Strategies for T1N0 Anal Canal Cancer.

Authors:  Ashish A Deshmukh; Hui Zhao; Prajnan Das; Elizabeth Y Chiao; Yi-Qian Nancy You; Luisa Franzini; David R Lairson; Michael D Swartz; Sharon H Giordano; Scott B Cantor
Journal:  Am J Clin Oncol       Date:  2018-07       Impact factor: 2.339

9.  Inefficiencies of over-screening and under-screening for cervical cancer prevention in the U.S.

Authors:  Philip E Castle; Cosette M Wheeler; Nicole G Campos; Stephen Sy; Emily A Burger; Jane J Kim
Journal:  Prev Med       Date:  2018-03-14       Impact factor: 4.018

10.  Optimal Cervical Cancer Screening in Women Vaccinated Against Human Papillomavirus.

Authors:  Jane J Kim; Emily A Burger; Stephen Sy; Nicole G Campos
Journal:  J Natl Cancer Inst       Date:  2016-10-18       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.